Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Is a Mass Immunization Program for Pandemic (H1N1) 2009 Good Value for Money? Early Evidence from the Canadian Experience.

Sander B, Bauch C, Fisman DN, Fowler R, Kwong JC, McGeer A, Zivkovic Gojovic M, Krahn M.

PLoS Curr. 2009 Dec 17;1:RRN1137.

2.

Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience.

Sander B, Bauch CT, Fisman D, Fowler RA, Kwong JC, Maetzel A, McGeer A, Raboud J, Scales DC, Gojovic MZ, Krahn M.

Vaccine. 2010 Aug 31;28(38):6210-20. doi: 10.1016/j.vaccine.2010.07.010. Epub 2010 Jul 17.

PMID:
20643091
3.
4.

Pan-Canadian assessment of pandemic immunization data collection: study methodology.

Pereira JA, Quach S, Heidebrecht C, Foisy J, Quan S, Finkelstein M, Sikora CA, Bettinger JA, Buckeridge DL, McCarthy A, Deeks S, Kwong JC; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network Vaccine Coverage Theme Group.

BMC Med Res Methodol. 2010 Jun 8;10:51. doi: 10.1186/1471-2288-10-51.

5.

Estimating background rates of Guillain-Barré Syndrome in Ontario in order to respond to safety concerns during pandemic H1N1/09 immunization campaign.

Deeks SL, Lim GH, Simpson MA, Rosella L, Mackie CO, Achonu C, Crowcroft NS.

BMC Public Health. 2011 May 17;11:329. doi: 10.1186/1471-2458-11-329.

6.

Pandemic influenza H1N1 2009--the Canadian experience.

Scott K.

J Popul Ther Clin Pharmacol. 2010 Fall;17(3):e358-62. Epub 2010 Oct 26.

PMID:
21041869
7.

[Mathematical modeling of the novel influenza A (H1N1) virus and evaluation of the epidemic response strategies in the Republic of Korea].

Suh M, Lee J, Chi HJ, Kim YK, Kang DY, Hur NW, Ha KH, Lee DH, Kim CS.

J Prev Med Public Health. 2010 Mar;43(2):109-16. doi: 10.3961/jpmph.2010.43.2.109. Korean.

8.

Antibodies against swine influenza virus neutralize the pandemic influenza virus A/H1N1.

Tsukamoto M, Hiroi S, Adachi K, Kato H, Inai M, Konishi I, Tanaka M, Yamamoto R, Sawa M, Handharyani E, Tsukamoto Y.

Mol Med Rep. 2011 Mar-Apr;4(2):209-14. doi: 10.3892/mmr.2011.410. Epub 2011 Jan 3.

PMID:
21468553
9.

Influenza immunization in Canada's low-income population.

Hobbs JL, Buxton JA.

BMC Public Health. 2014 Jul 21;14:740. doi: 10.1186/1471-2458-14-740.

10.

Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.

Mahmud S, Hammond G, Elliott L, Hilderman T, Kurbis C, Caetano P, Van Caeseele P, Kettner J, Dawood M.

Vaccine. 2011 Oct 19;29(45):7975-81. doi: 10.1016/j.vaccine.2011.08.068. Epub 2011 Aug 30.

PMID:
21884747
11.

Modelling mitigation strategies for pandemic (H1N1) 2009.

Gojovic MZ, Sander B, Fisman D, Krahn MD, Bauch CT.

CMAJ. 2009 Nov 10;181(10):673-80. doi: 10.1503/cmaj.091641. Epub 2009 Oct 13.

12.

Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.

Skowronski DM, Janjua NZ, De Serres G, Hottes TS, Dickinson JA, Crowcroft N, Kwindt TL, Tang P, Charest H, Fonseca K, Gubbay JB, Bastien N, Li Y, Petric M.

BMJ. 2011 Feb 3;342:c7297. doi: 10.1136/bmj.c7297.

13.

Economic evaluation of the vaccination program against seasonal and pandemic A/H1N1 influenza among customs officers in Greece.

Mamma M, Spandidos DA.

Health Policy. 2013 Jan;109(1):71-7. doi: 10.1016/j.healthpol.2012.10.013. Epub 2012 Nov 26.

PMID:
23195436
14.

A cost comparison of electronic and hybrid data collection systems in Ontario during pandemic and seasonal influenza vaccination campaigns.

Pereira JA, Foisy J, Kwong JC, Heidebrecht CL, Quach S, Quan SD, Guay M, Sander B; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Vaccine Coverage Theme Group.

BMC Health Serv Res. 2011 Sep 1;11:210. doi: 10.1186/1472-6963-11-210.

15.

Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009.

Khazeni N, Hutton DW, Garber AM, Hupert N, Owens DK.

Ann Intern Med. 2009 Dec 15;151(12):829-39. doi: 10.7326/0003-4819-151-12-200912150-00157.

16.

Nationwide surveillance of influenza during the pandemic (2009-10) and post-pandemic (2010-11) periods in Taiwan.

Chuang JH, Huang AS, Huang WT, Liu MT, Chou JH, Chang FY, Chiu WT.

PLoS One. 2012;7(4):e36120. doi: 10.1371/journal.pone.0036120. Epub 2012 Apr 24.

17.

Modelling the transmission dynamics and control of the novel 2009 swine influenza (H1N1) pandemic.

Sharomi O, Podder CN, Gumel AB, Mahmud SM, Rubinstein E.

Bull Math Biol. 2011 Mar;73(3):515-48. doi: 10.1007/s11538-010-9538-z. Epub 2010 Apr 9.

PMID:
20379852
18.

Outbreak of 2009 pandemic influenza A (H1N1) on a Peruvian Navy ship - June-July 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 Feb 19;59(6):162-5.

19.

Perceptions of immunization information systems for collecting pandemic H1N1 immunization data within Canada's public health community: a qualitative study.

Heidebrecht CL, Foisy J, Pereira JA, Quan SD, Willison DJ, Deeks SL, Finkelstein M, Crowcroft NS, Buckeridge DL, Guay M, Sikora CA, Kwong JC; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network Vaccine Coverage Theme Group.

BMC Public Health. 2010 Aug 31;10:523. doi: 10.1186/1471-2458-10-523.

20.

Socioeconomic burden of influenza in the Republic of Korea, 2007-2010.

Suh M, Kang DR, Lee DH, Choi YJ, Tchoe B, Nam CM, Kim HJ, Lee JK, Jun BY, Youm Y, Bae GN, Lee TY, Kim MS, Shin DC, Kim C.

PLoS One. 2013 Dec 27;8(12):e84121. doi: 10.1371/journal.pone.0084121. eCollection 2013.

Supplemental Content

Support Center